Intellia Therapeutics, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC NTLA

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

945,756

Value ($000)

8,502

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	8,502	0.0%	945,756	12/31/2025
2025 Q3	11/10/2025	15,080	0.0%	873,188	9/30/2025
2025 Q2	8/12/2025	8,034	0.0%	856,549	6/30/2025
2025 Q1	9/15/2025	5,547	0.0%	780,224	3/31/2025
2024 Q4	2/6/2025	9,182	0.0%	787,490	12/31/2024
2024 Q3	11/12/2024	17,006	0.0%	827,545	9/30/2024
2024 Q2	8/12/2024	17,676	0.0%	789,831	6/30/2024
2024 Q1	5/9/2024	20,035	0.0%	728,295	3/31/2024
2023 Q4	2/6/2024	21,350	0.0%	700,228	12/31/2023
2023 Q3	11/8/2023	21,541	0.0%	681,241	9/30/2023
2023 Q2	8/10/2023	38,852	0.0%	952,717	6/30/2023
2023 Q1	5/12/2023	32,394	0.0%	869,172	3/31/2023
2022 Q4	2/13/2023	31,144	0.0%	892,631	12/31/2022
2022 Q3	11/14/2022	43,200	0.0%	771,975	9/30/2022
2022 Q2	8/15/2022	36,928	0.0%	713,445	6/30/2022
2022 Q1	5/13/2022	50,605	0.0%	696,367	3/31/2022
2021 Q4	2/11/2022	80,631	0.0%	681,921	12/31/2021
2021 Q3	11/16/2021	89,455	0.0%	666,822	9/30/2021
2021 Q2	8/16/2021	74,041	0.0%	457,297	6/30/2021
2021 Q1	5/17/2021	34,608	0.0%	431,216	3/31/2021
2020 Q4	2/16/2021	20,152	0.0%	370,433	12/31/2020
2020 Q3	11/13/2020	6,794	0.0%	341,742	9/30/2020
2020 Q2	8/20/2020	6,323	0.0%	300,805	6/30/2020
2020 Q1	5/15/2020	3,020	0.0%	246,878	3/31/2020
2019 Q4	2/7/2020	3,583	0.0%	244,195	12/31/2019